Tilaknagar Industries Q4 FY26: Imperial Blue Integration Starts Showing Up in Scale

Tilaknagar Industries ended FY26 with a step change in scale, driven by the Imperial Blue acquisition and steady growth in its legacy franchise. FY26 volumes reached about 20 million cases even though Imperial Blue was under Tilaknagar’s ownership for only four months of the year. Q4 FY26 was the first full quarter of Imperial Blue operations under the company and that was reflected in sharply higher reported volumes and revenue.

In Q4 FY26, the company reported net revenue of INR 949 crore compared with INR 384 crore in Q4 FY25. EBITDA for the quarter was INR 155 crore, with an EBITDA margin of 16.3%. Management also presented profitability adjusted for subsidy, where Q4 EBITDA was highlighted at INR 146 crore with a 15.5% margin. The quarter included exceptional costs linked largely to the transition services and manufacturing arrangement.

For the full year, net revenue rose to INR 2,346 crore from INR 1,381 crore in FY25. EBITDA increased to INR 419 crore from INR 255 crore. On an adjusted basis for subsidy income, management highlighted FY26 EBITDA of INR 352 crore with a 15.5% margin. While reported profit lines were impacted by exceptional items and acquisition related amortisation, management’s narrative focused on integration progress, cost optimisation and a multi-year plan to improve margins and reduce leverage.

Q4 and FY26 snapshot: volume-led expansion with integration costs

The combined business delivered 8.0 million cases in Q4 FY26, up 134% year on year. Imperial Blue contributed 4.6 million cases, while the ex-Imperial Blue portfolio was largely flat in the quarter. Management attributed the muted base business growth to an unusually strong Q4 FY25 in Andhra Pradesh following a route-to-market shift.

Net sales realisation for the combined business rose 5.4% year on year in Q4 to INR 1,177 per case. For the full year, NSR was broadly flat at INR 1,165 per case, with management attributing the decline to a price reduction in Andhra Pradesh in Q3 FY25.

A key accounting presentation change also affects comparability. The company now nets selling expenses such as discounts and schemes from gross revenue rather than showing them within other expenses. Management stated this change reduces reported revenue and gross margin but does not impact absolute EBITDA, PAT or EPS. The change was positioned as improving comparability with peers after the business mix expanded into multiple non-corporation market states.

Integration update: TSMA exits, cost levers, and the next 24 months

Post-acquisition integration is the operational centrepiece for Tilaknagar. Management stated that around 75% of Imperial Blue volumes had moved under Tilaknagar’s operations, with only three states still under the transition services and manufacturing arrangement. The company also quantified a decline in transition costs, with average monthly TSMA expenses reducing to about INR 14 crore in Q4 FY26 from INR 22 crore in Q3 FY26.

Management acknowledged that the shift caused small business disruptions in the first couple of weeks of April 2026, but stated that Imperial Blue sales rebounded in May with record volumes under Tilaknagar ownership. The company guided that full transition should complete by end of FY27, with March 2027 cited as an outer timeline.

The margin roadmap is built on a mix of integration-related savings and structural cost initiatives. The investor presentation states that cost savings can deliver 250 to 400 basis points of margin expansion on the acquired business within 24 months. Levers cited include packaging initiatives, bottling charge improvements through new arrangements with bottlers, and leaner overhead structures. Management also referenced the potential benefit from the India-UK FTA on scotch customs duty, stating it would primarily benefit Imperial Blue, with a combined business margin benefit estimated at 60 to 100 basis points.

Near-term, management flagged input cost pressure due to geopolitical tensions. They indicated Q1 FY27 could see temporary impact, but reiterated their multi-year margin target.

Balance sheet reset after acquisition: leverage up, deleveraging plan outlined

The acquisition transformed the capital structure. As of March 2026, the company reported gross debt of INR 2,295 crore and net debt of INR 1,911 crore. The term loan carries a six-year tenor with a two-year principal moratorium and a balloon repayment structure. Management stated the effective interest rate is around 10% to 11%.

Cash flow in FY26 was acquisition-heavy and working capital intensive. Net cash from operating activities was negative INR 445 crore, with working capital change of negative INR 649 crore. Net investing cash flow was negative INR 3,570 crore, while financing cash flow was positive INR 4,217 crore.

Despite the step-up in leverage, management reiterated a clear deleveraging target. The company aims to reduce net debt to EBITDA below 1.0x by FY29. In the call, management also guided that net debt could reduce to around INR 1,700 crore by March 2027.

The board recommended a dividend of INR 1 per equity share for FY26, signalling confidence while still highlighting debt reduction as a key priority.

Portfolio strategy: using Imperial Blue distribution to push premium and luxury

Tilaknagar’s medium-term strategy is not only integration but also portfolio expansion. Management described Imperial Blue as a premiumization lever and highlighted the ambition to proliferate premium brands using its pan-India distribution reach. The company stated plans to expand Seven Islands Pure Malt Whisky and the Spaceman Spirits Lab portfolio into more than 10 states over the next 12 to 18 months.

The investor presentation positioned a luxury push as a central theme, listing Seven Islands Pure Malt Whisky and Monarch Legacy Edition brandy as key launches, and SSL brands such as Samsara gin, Amara vodka, and Sitara rum. The presentation also stated an ambition to expand key account establishments from under 500 in 2025 to about 1,400 in 2026, with a longer-term target of more than 10,000 by 2030E.

In the concall, management also stated that brandy expansion into northern markets is planned in FY27, covering both mass and mid-prestige offerings as well as the luxury Monarch brand.

Takeaways

FY26 marks the beginning of Tilaknagar’s transition from a brandy-heavy regional player to a broader pan-India platform with scale in whisky and brandy. Q4 FY26 showed what the combined business looks like once Imperial Blue is fully inside the quarter, but reported profitability still carries integration-related exceptional costs.

The near-term investor focus is likely to be on three things: completing TSMA exits without disruption, translating identified cost levers into sustained EBITDA margins, and improving working capital discipline after a negative operating cash flow year. Management’s guidance is explicit on where the company wants to land by FY29: 16% to 18% EBITDA margins and net debt to EBITDA below 1.0x. The next few quarters will test execution against that roadmap.